Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
CAMBRIDGE, Mass., Sept. 25, 2024 ( GLOBE NEWSWIRE ) -- Wave Life Sciences Ltd. ( Nasdaq: WVE ) , a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, announced today the pricing of its previously announced underwritten public ...
| Ticker |
Sentiment |
Impact |
|
BR
|
Neutral
|
5 %
|
|
STT
|
Neutral
|
5 %
|
|
WVE
|
Somewhat Bullish
|
31 %
|
